Sort
51,593 grants matching “hepatitis”
Environmental Obesogens and Weight Change in the POUNDS LOST Trial
$532,753Qi Sun · Harvard School Of Public Health · R01 · FY2016 · ES
Collagen fibers and fragments regulate pancreatic cancer metabolism and growth
$532,713Michael Karin · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2025 · CA
Apolipoprotein A-l and HDL: Structure, Formation and Function
$532,707David Atkinson · Boston University Medical Campus · R01 · FY2015 · HL
Descriptive Studies and Record Linkage
$532,689Meredith Shiels · Division Of Cancer Epidemiology And Genetics · ZIA · FY2023 · CA
Targeting matrix stiffness in lung and liver fibrosis
$532,636Daniel J. Tschumperlin · Mayo Clinic Rochester · R01 · FY2019 · HL
Glycosylation Mutants of Mice and Animal Cells
$532,632Pamela M Stanley · Albert Einstein College Of Medicine · R01 · FY2010 · CA
The UPR and CaMKIIg in Atherosclerosis and Insulin Resistance
$532,486Ira A Tabas · Columbia University Health Sciences · P01 · FY2014 · HL
Increasing the Capacity of a Community-Based Research Center to Address Opioid Use Disorder and Related Health Inequities in Urban American Indian Communities
$532,452Antony Stately · Native American Community Clinic · OT2 · FY2025 · DA
Resource for Rat Genetic Models of Aerobic Capacity
$532,439Steven Loyal Britton · University Of Michigan At Ann Arbor · P40 · FY2015 · OD
Applied Research Component: Cryopreservation
$532,439Steven Loyal Britton · University Of Michigan At Ann Arbor · P40 · FY2015 · OD
Fibroblast growth factor 1 prevents hyperlipidemia and atherosclerosis
$532,418Yi Tan · University Of Louisville · R01 · FY2025 · HL
Characterization of HCV vaccine induced-neutralizing antibody response in non-human primates
$532,252Pamela J Bjorkman · Johns Hopkins University · U19 · FY2025 · AI
Protective and fibrosis-independent functions of hepatic stellate cells
$532,209Robert F. Schwabe · Columbia University Health Sciences · R01 · FY2022 · DK
Improving hepatocellular carcinoma mouse modeling by understanding the malignant potential and biology of liver cell subpopulations
$532,170Hao Zhu · Ut Southwestern Medical Center · R01 · FY2023 · CA
Improving hepatocellular carcinoma mouse modeling by understanding the malignant potential and biology of liver cell subpopulations
$532,168Hao Zhu · Ut Southwestern Medical Center · R01 · FY2022 · CA
Epidemiology and Natural History of Cancer-Associated Viruses
$532,148Sam M Mbulaiteye · Division Of Cancer Epidemiology And Genetics · ZIA · FY2019 · CA
Development of Controlled Release Mitochondrial Protonophore (CRMP) as a Novel Treatment for Type-2 Diabetes and Non-Alcoholic Steatohepatitis in Dysmetabolic Non-Human Primates
$532,148Gerald I Shulman · Yale University · R01 · FY2023 · DK
Coactivator P300 promotes hepatic steatosis in obesity
$532,127Ling He · Johns Hopkins University · R01 · FY2022 · DK
Impact of Tetracycline Antibiotics on Skeletal Maturation
$532,119Caroline Westwater · Medical University Of South Carolina · R01 · FY2023 · AR
Molecular Organization of Renal and Hepatic Organic Cation Transporters
$532,109Stephen H Wright · University Of Arizona · R01 · FY2015 · DK
Molecular Organization of Renal and Hepatic Organic Cation Transporters
$532,109Stephen H Wright · University Of Arizona · R01 · FY2014 · DK
Yale Drug use, Addiction and HIV Research Scholars (DAHRS)
$532,108Gail D'onofrio · Yale University · K12 · FY2019 · DA
Phospholipid-Mediated Metabolic Control in the Liver
$532,098David E Cohen · Weill Medical Coll Of Cornell Univ · R01 · FY2017 · DK
Insulin Resistance in Vascular Endothelial Cells and Foxo
$531,959Domenico Accili · Columbia University Health Sciences · P01 · FY2015 · HL
Intestine FXR activation by LGG-derived nanoparticles in alcohol-associated liver disease
$531,959Wenke Feng · University Of Louisville · R01 · FY2022 · AA